SeekingAlpha
Imunon, Inc. (NASDAQ:IMNN) Q1 2025 Earnings Conference Call May 12, 2025 11:00 AM ETCompany ParticipantsPeter Vozzo - ICR Healthcare, Investor...
Yahoo
Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented Initiation of Phase 3 trial sites underway for pivotal study of IMNN-001 following alignment on protocol with FDA LAWRENCEVILLE, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that an abstract highlighting new, highly encouraging, Overall Survival data f
Yahoo
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On March 24, 2025, Imunon, Inc. (NASDAQ:IMNN) announced it reached alignment with the U.S. FDA on the protocol for a Phase 3 clinical trial, referred to as OVATION 3, of its lead candidate IMNN-001 for the treatment of women with newly diagnosed
Yahoo
Imunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.
Yahoo
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3 pivotal trial of DNA-mediated IL-12 therapeutic Company to hold conference call on Tuesday, March 25, 2025, at 2:00 p.m. ET LAWRENCEVILLE, N.J., March 24, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today anno
Yahoo
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Phase 3 Ovarian Cancer Trial to Initiate in March 2025 Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of its lead development compound, IMNN-001, in patients with advanced ovarian cancer. IMNN-001 is a DNA immunotherapeutic drug that consists of an interleukin (IL)-12
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
JUCY | -15.20% | $298.07M | 0.6% |
TBLL | -13.69% | $2.46B | 0.08% |
IBTF | -11.60% | $2.12B | 0.07% |
GBIL | -9.38% | $6.17B | 0.12% |
SMH | -8.72% | $21.25B | 0.35% |
KCCA | -8.52% | $97.87M | 0.87% |
TPMN | -7.96% | $31.21M | 0.65% |
PSI | -7.87% | $657.47M | 0.56% |
FTXL | -7.74% | $246.86M | 0.6% |
SOXQ | -7.56% | $436.76M | 0.19% |
IVOL | -7.48% | $351.97M | 1.02% |
AIPI | -7.28% | $286.54M | 0.65% |
IBTH | -7.06% | $1.52B | 0.07% |
CORN | -6.91% | $50.03M | 0.2% |
VGSH | -6.88% | $22.92B | 0.03% |
IBTG | -6.53% | $1.88B | 0.07% |
ULST | -6.48% | $637.67M | 0.2% |
CLSE | -6.42% | $175.16M | 1.44% |
SOXX | -6.34% | $12.40B | 0.35% |
XLK | -6.32% | $70.24B | 0.09% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PLOW | 49.49% | $671.68M | +13.36% | 4.07% |
HSII | 43.46% | $884.01M | +23.33% | 1.37% |
CVLT | 41.10% | $7.93B | +59.93% | 0.00% |
HLIT | 40.98% | $1.09B | -15.04% | 0.00% |
VRNS | 40.84% | $5.12B | +2.58% | 0.00% |
FFIV | 38.27% | $16.17B | +60.86% | 0.00% |
SEG | 37.01% | $244.37M | -25.25% | 0.00% |
BRX | 34.52% | $7.85B | +14.92% | 4.39% |
LGIH | 34.14% | $1.34B | -46.58% | 0.00% |
CNO | 33.57% | $3.81B | +35.34% | 1.66% |
FISI | 32.83% | $541.55M | +45.57% | 4.46% |
TENB | 32.55% | $4.03B | -26.18% | 0.00% |
KRG | 32.39% | $4.96B | +6.81% | 4.63% |
RNGR | 32.20% | $272.00M | +15.92% | 2.27% |
BFS | 31.67% | $796.94M | -11.79% | 7.15% |
HWM | 31.42% | $64.37B | +92.70% | 0.23% |
SFM | 29.66% | $15.51B | +106.25% | 0.00% |
SWK | 29.11% | $11.12B | -21.37% | 4.57% |
RGEN | 28.62% | $7.19B | -27.26% | 0.00% |
HAYW | 28.41% | $3.13B | -3.60% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
QCLN | <0.01% | $402.05M | 0.59% |
FLQL | -0.01% | $1.42B | 0.29% |
BSCR | -0.01% | $3.48B | 0.1% |
BBAG | 0.01% | $1.21B | 0.03% |
AVIG | -0.02% | $1.06B | 0.15% |
SFYF | 0.03% | $24.00M | 0.29% |
EJAN | -0.03% | $113.10M | 0.89% |
GCOR | -0.03% | $535.79M | 0.08% |
BSCT | -0.04% | $1.97B | 0.1% |
VUSB | 0.04% | $5.40B | 0.1% |
TIP | 0.05% | $13.72B | 0.18% |
IGV | 0.06% | $11.84B | 0.41% |
DFIP | -0.07% | $875.08M | 0.11% |
NUKZ | 0.07% | $211.17M | 0.85% |
FV | -0.08% | $3.58B | 0.87% |
SCHQ | -0.08% | $832.77M | 0.03% |
OEF | 0.08% | $17.59B | 0.2% |
SPIB | 0.09% | $9.19B | 0.04% |
JCPB | 0.09% | $6.24B | 0.38% |
FXI | 0.09% | $6.11B | 0.74% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
QXO | -44.51% | $8.32B | -84.77% | 0.00% |
WWD | -42.56% | $12.26B | +15.33% | 0.50% |
AMKR | -30.17% | $4.96B | -39.62% | 1.63% |
ECL | -28.96% | $70.92B | +7.38% | 0.97% |
MBIN | -26.88% | $1.50B | -24.00% | 1.14% |
LTC | -25.56% | $1.61B | +1.42% | 6.47% |
MRK | -24.45% | $184.49B | -44.23% | 4.28% |
PG | -19.81% | $370.48B | -5.10% | 2.56% |
SYM | -19.39% | $3.05B | -40.02% | 0.00% |
NVAX | -19.23% | $965.34M | -53.80% | 0.00% |
PSN | -17.07% | $7.14B | -13.55% | 0.00% |
LITB | -16.87% | $22.99M | -70.67% | 0.00% |
BMO | -16.59% | $74.66B | +7.56% | 4.41% |
GTY | -15.82% | $1.55B | -1.17% | 6.54% |
TLK | -15.48% | $15.66B | -19.30% | 6.81% |
NVDA | -15.38% | $3.30T | +43.02% | 0.03% |
RMBS | -15.34% | $6.19B | -3.14% | 0.00% |
BHE | -14.24% | $1.35B | -9.05% | 1.81% |
CAMT | -14.14% | $3.18B | -30.44% | 0.00% |
TRS | -13.83% | $980.52M | -12.39% | 0.66% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILZ | 40.21% | $880.81M | 0.14% |
KIE | 16.24% | $947.37M | 0.35% |
XMLV | 15.03% | $824.79M | 0.25% |
PBDC | 14.86% | $208.37M | 13.94% |
RSPH | 14.56% | $769.59M | 0.4% |
BIZD | 14.47% | $1.50B | 13.33% |
IAK | 14.31% | $784.49M | 0.39% |
XSLV | 14.27% | $291.79M | 0.25% |
PEY | 14.03% | $1.13B | 0.53% |
FDL | 13.91% | $5.37B | 0.45% |
FXG | 13.66% | $311.86M | 0.63% |
RPV | 13.58% | $1.34B | 0.35% |
FTA | 13.49% | $1.10B | 0.6% |
SCHD | 13.38% | $68.56B | 0.06% |
SMMV | 13.32% | $307.19M | 0.2% |
DIV | 13.00% | $638.86M | 0.45% |
REGL | 12.81% | $1.77B | 0.4% |
RWJ | 12.73% | $1.50B | 0.39% |
DHS | 12.71% | $1.21B | 0.38% |
XSHD | 12.67% | $70.34M | 0.3% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
SCHW | <0.01% | $158.37B | +10.78% | 1.19% |
STZ | -0.01% | $33.24B | -25.97% | 2.17% |
COOP | 0.01% | $8.24B | +54.95% | 0.00% |
PBT | -0.02% | $485.20M | -20.11% | 3.99% |
MGNI | 0.03% | $2.34B | +69.29% | 0.00% |
WBX | -0.03% | $96.98M | -77.90% | 0.00% |
HSTM | -0.03% | $826.63M | -0.66% | 0.32% |
ANAB | -0.03% | $571.45M | -24.02% | 0.00% |
ZYXI | 0.04% | $63.50M | -80.93% | 0.00% |
VOD | -0.04% | $22.47B | -6.22% | 7.81% |
EMR | 0.04% | $68.33B | +5.79% | 1.74% |
ALLT | 0.04% | $329.45M | +282.49% | 0.00% |
KDP | 0.05% | $44.44B | -3.22% | 2.75% |
KN | 0.06% | $1.48B | -2.41% | 0.00% |
ENR | 0.06% | $1.67B | -24.86% | 5.16% |
SKYW | -0.06% | $4.14B | +32.76% | 0.00% |
RKLB | 0.06% | $11.13B | +455.99% | 0.00% |
MANU | 0.07% | $2.46B | -14.42% | 0.00% |
GILT | 0.07% | $379.16M | +20.04% | 0.00% |
HCA | 0.07% | $88.41B | +12.40% | 0.73% |
Current Value
$0.601 Year Return
Current Value
$0.601 Year Return